Pharma Focus Asia - Special Issue on R&D, Manufacturing

Unable to view this mail? Please click here to view in browser

Pharmaceutical Competitive Strategy

ExpreS2ion Biotechnologies

Novo Nordisk Insulin Facility

Emerging Biotechnologies

e-Newsletter

www.pharmafocusasia.com | Archives | Advertise

News

WuXi PharmaTech announces shareholders approval of Merger Agreement

Taro Pharma drops plan to invest in Suzlon’s US power project

AstraZeneca sells U.S. drug rights to Perrigo for $380 million

Press Releases

ESSA Announces Enrollment of First Patient in Phase 12 Trial

Impax Launches Generic Version of Avodart Dutasteride Capsules

Array BioPharma To Present At The Piper Jaffray Annual Healthcare Conference

Events

01 -03 Dec 2015
Pathology 2015

01 -03 Dec 2015
CPhI & PMEC India 2015

15 -17 Dec 2015
MEPHEX Abu Dhabi 2015

Articles
Competing on Alignment *Brian D Smith* Principal Advisor , PragMedic, UK SWOT is both the most powerful and least understood strategic management tool. Used correctly, it translates the outputs of many other market analyses into a small number of key issues.Consultants often use military analogies, comparing competitors to enemies and strategies to battle plans...
Interviews
ExpreS2ion Biotechnologies ExpreS2ion Biotechnologies’ protein expression system ExpreS2 is an important protein expression tool in the scientist’s tool box for protein expression. The ExpreS2 platform has demonstrated in many instances its usefulness in R&D, with several ExpreS2-made proteins having now been ...
Projects
Novo Nordisk invests DKK 2.1 billion in new insulin filling facility in Hillerød, Denmark Novo Nordisk announced plans to invest DKK 2.1 billion in a new 10,300 m2 facility in Hillerød, Denmark.The facility will produce medicines for the treatment of diabetes and obesity. The facility is expected to be operational in 2019 and will create 450 new production and engineering...
Reports
Emerging Biotechnologies – Gene Therapy Market Analysis Cushing’s Syndrome – Opportunity Analysis and Forecasts to 2018 Mid-Cap Biotechnology Benchmark Report – Sales Forecasts and Product Valuations of Innovative Biotechs

Editorial Calender

Media Pack

e-Magazine| Subscribe | Unsubscribe

www.pharmafocusasia.com – a product of Ochre Media Pvt. Ltd.
Ochre Media Pvt Ltd. Media Resource Centre, 2nd Floor, Oxford Plaza, Secunderabad - 500 003, Telangana, India
Tel: +91 40 4961 4567 | Fax: +91 40 4961 4555